Cancer Immunotherapy Winter School (CIWS)

癌症免疫治疗冬季学校（CIWS）

• 批准号: 10391811
• 负责人: Catherine M. Bollard
• 金额: $ 3万
• 依托单位: SOCIETY FOR IMMUNOTHERAPY OF CANCER, INC.
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10391811
• 关键词: Accreditation; Address; Advocate; Area; Award; Biological Markers; Cancer Patient; Charge; Clinical; Clinical Trials; Clinical Trials Design; Combined Modality Therapy; Continuing Education; Data Analyses; Development; Discrimination; Education; Educational Materials; Educational process of instructing; Emergency Department Physician; Ensure; Faculty; Feedback; Fees; Foundations; Funding; Future; Government; Grant; Health Professional; Healthcare; Immunology; Immunotherapy; Industry; International; Joints; Knowledge; Leadership; Learning; Location; Logistics; Medical; Mentorship; Methods; Mission; Modality; Nurses; Oncologist; Participant; Patient-Focused Outcomes; Patients; Persons; Pharmacists; Physicians; Process Assessment; Psychological reinforcement; Research; Schools; Science; Scientific Advances and Accomplishments; Scientist; Self-Direction; Societies; Structure; Teaching Method; Translations; Travel; Underrepresented Populations; United States; United States National Institutes of Health; austin; cancer care; cancer immunotherapy; cancer site; career; career networking; clinical application; continuing medical education; cost; design; educational atmosphere; experience; improved; innovation; insight; meetings; member; peer; programs; success; technology validation; translational physician; translational scientist; tumor immunology

4.0 PROJECT SUMMARY/ABSTRACT Established in 1984, the Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. The mission of SITC is to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. At the forefront of SITC’s educational charge is the Cancer Immunotherapy Winter School (CIWS) program. The 2022 program in Austin, TX will focus on delivering a program designed to enable basic, clinical, or translational scientists and clinicians from the entire cancer care team including those from diverse and underrepresented groups in biomedical sciences, to advance scientific discoveries and clinical applications of tumor immunology and cancer immunotherapy. This comprehensive, five-day accredited CME-/CNE-/CPE-/MOC-certified program will provide a deep understanding of the core principles of tumor immunology, cancer immunotherapy and developing areas in the field. With 51 topics including foundational immunology, clinical trial design, combination therapies, biomarker integration and data analysis, attendees have a number of session types (all- attendee, breakout, research/clinical tracks) tailored to maximize learning opportunities and styles through selection of sessions most relevant to their educational needs. This allows for many opportunities of personalized interaction between attendees and experts. Attendees, through small group sessions and networking roundtables, will expand their professional network, developing new relationships with faculty and other thought leaders. These hands-on sessions will provide valuable networking and mentorship opportunities, and poise questions from their own experiences. Designed and approved by experts across the healthcare spectrum—clinical physicians, nurses, pharmacists, emergency physicians, and patient advocates—establishes that all points of view are incorporated. For attendees of in-person courses, enduring materials are available following the program and will serve as reinforcement of their learnings and allow access to other concurrent sessions they could not attend. Materials are available to the public six months later at a nominal fee. SITC, program organizers, and faculty certifies the CIWS is open to all who wish to attend and it is a safe and respectful learning environment free from all forms of discrimination and harassment. Low registration rates, travel awards, ADA-compliant facilities, and a centralized location ensures that obstacles do not stand in the way of physicians’ knowledge and eventual use of these revolutionary treatments. SITC is uniquely poised to hold this premier, educational option for all healthcare professionals and every type of learner. NIH support for this program will allow for continued educational and professional advancement for the entire cancer care team, in addition to networking opportunities with peers and leaders in the field.

4.0 项目概要/摘要 癌症免疫治疗协会 (SITC) 成立于 1984 年，是世界领先的会员驱动型协会 专门致力于通过推进科学和技术来改善癌症患者治疗结果的组织 癌症免疫疗法的应用。 SITC 的使命是通过以下方式改善癌症患者的治疗结果 通过我们的研究，推进癌症免疫学和免疫治疗的科学、发展和应用 互动/整合、创新、转化和领域领导力的核心价值观。走在前列 SITC 的教育任务是癌症免疫治疗冬季学校 (CIWS) 项目。 2022 年计划 德克萨斯州奥斯汀将专注于提供旨在使基础、临床或转化科学家和 来自整个癌症护理团队的临床医生，包括来自不同和代表性不足群体的临床医生 生物医学科学，推进肿瘤免疫学的科学发现和临床应用 癌症免疫疗法。这个为期五天的综合性 CME-/CNE-/CPE-/MOC 认证课程将 深入了解肿瘤免疫学、癌症免疫治疗的核心原理和 该领域的发展领域。拥有基础免疫学、临床试验设计等51个主题， 联合疗法、生物标志物整合和数据分析，与会者有多种会议类型（所有- 与会者、突破、研究/临床轨道）量身定制，通过以下方式最大限度地提高学习机会和风格 选择与他们的教育需求最相关的课程。这提供了许多机会 与会者和专家之间的个性化互动。与会者通过小组会议和 网络圆桌会议，将扩大他们的专业网络，与教师和 其他思想领袖。这些实践课程将提供宝贵的网络和指导 机会，并根据自己的经历提出问题。经全球专家设计和批准 医疗保健范围——临床医生、护士、药剂师、急诊医生和患者 倡导者——确定所有观点均被纳入。对于现场课程的参加者来说，持久 课程结束后将提供材料，这些材料将作为他们学习的强化，并允许 访问他们无法参加的其他并发会议。六个月后，材料将向公众开放 象征性收费。 SITC、项目组织者和教师证明 CIWS 对所有希望参加​​的人开放 这是一个安全和尊重的学习环境，没有任何形式的歧视和骚扰。低的 登记率、旅行奖励、符合 ADA 标准的设施和集中位置确保障碍物不会 不妨碍医生了解这些革命性疗法并最终使用它们。国际贸易标准分类是 独特的准备为所有医疗保健专业人员和各种类型的人提供这一首要的教育选择 学习者。 NIH 对该计划的支持将允许继续教育和专业进步 整个癌症护理团队，以及与该领域同行和领导者建立联系的机会。